HCA Healthcare, Inc. (NYSE:HCA) Stock Position Increased by Proficio Capital Partners LLC

Proficio Capital Partners LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 43,546.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 223,468 shares of the company's stock after buying an additional 222,956 shares during the period. Proficio Capital Partners LLC owned about 0.09% of HCA Healthcare worth $67,074,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. First Horizon Advisors Inc. grew its position in HCA Healthcare by 2.4% during the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company's stock worth $623,000 after buying an additional 36 shares during the period. Mediolanum International Funds Ltd grew its holdings in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the period. Hartford Funds Management Co LLC boosted its position in HCA Healthcare by 1.6% during the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company's stock worth $1,003,000 after purchasing an additional 39 shares in the last quarter. Prairie Wealth Advisors Inc. increased its position in shares of HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after buying an additional 40 shares in the last quarter. Finally, Financial Counselors Inc. grew its stake in HCA Healthcare by 3.0% in the 3rd quarter. Financial Counselors Inc. now owns 1,551 shares of the company's stock valued at $630,000 after acquiring an additional 45 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HCA shares. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $385.67.

HCA Healthcare Stock Up 1.6 %

Shares of NYSE:HCA traded up $4.81 during midday trading on Monday, reaching $311.11. The company had a trading volume of 1,408,429 shares, compared to its average volume of 1,731,760. The stock's fifty day moving average price is $315.15 and its 200-day moving average price is $349.23. The stock has a market capitalization of $77.26 billion, a P/E ratio of 14.16, a PEG ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company posted $5.90 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.93%. HCA Healthcare's dividend payout ratio is 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.